[go: up one dir, main page]

SE8100276L - Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar - Google Patents

Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar

Info

Publication number
SE8100276L
SE8100276L SE8100276A SE8100276A SE8100276L SE 8100276 L SE8100276 L SE 8100276L SE 8100276 A SE8100276 A SE 8100276A SE 8100276 A SE8100276 A SE 8100276A SE 8100276 L SE8100276 L SE 8100276L
Authority
SE
Sweden
Prior art keywords
ketons
heterocyclic compounds
active composition
pharmaceutical active
benzodiazepine
Prior art date
Application number
SE8100276A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
A W Peck
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE8100276L publication Critical patent/SE8100276L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8100276A 1980-01-21 1981-01-20 Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar SE8100276L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8001910 1980-01-21

Publications (1)

Publication Number Publication Date
SE8100276L true SE8100276L (sv) 1981-07-22

Family

ID=10510765

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100276A SE8100276L (sv) 1980-01-21 1981-01-20 Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar

Country Status (13)

Country Link
US (2) US4571395A (de)
JP (1) JPS56104819A (de)
AU (1) AU552261B2 (de)
BE (1) BE887151A (de)
CA (1) CA1166157A (de)
CH (1) CH647150A5 (de)
DE (1) DE3101644A1 (de)
FR (1) FR2473884B1 (de)
IT (1) IT1142259B (de)
NL (1) NL8100259A (de)
NZ (1) NZ196048A (de)
SE (1) SE8100276L (de)
ZA (1) ZA81380B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
DE3685766T2 (de) * 1985-04-18 1993-02-11 Fuji Chem Ind Co Ltd Photolackbildherstellungsverfahren.
US5206238A (en) * 1990-11-13 1993-04-27 Merck & Co., Inc. Cholecystokinin antagonists
GB9217295D0 (en) * 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) * 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
US5358970A (en) * 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) * 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
CA2318920A1 (en) * 1998-01-29 1999-08-05 James W. Young Pharmaceutical uses of optically pure (-)-bupropion
JP2002501891A (ja) 1998-01-29 2002-01-22 セプラコア インコーポレーテッド 光学的に純粋な（＋）−ビュープロピオンの医薬用途
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
EP2120945A1 (de) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamin-kombination
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
US11291639B2 (en) 2018-09-20 2022-04-05 Axsome Therapeutics, Inc. Dosage forms and methods for enantiomerically enriched or pure bupropion
WO2022082058A1 (en) * 2020-10-16 2022-04-21 Eleusis Therapeutics Us, Inc. Method of treatment by tryptamine alkaloids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA665638A (en) * 1963-06-25 L. Bolling Charles Ataractic compositions
FR2817M (fr) * 1962-07-02 1964-09-28 Merck & Co Inc Associations de médicaments pour le traitement des désordres mentaux.
NL136835C (de) * 1965-12-03
GB1340032A (en) * 1969-12-04 1973-12-05 Wellcome Found Biologically active ketones
BE793775A (fr) * 1972-01-10 1973-07-09 Hoffmann La Roche Procede pour la stabilisation de comprimes pharmaceutiques
US4017619A (en) * 1973-10-26 1977-04-12 Burnap Raymond W Anesthetic and sedative composition

Also Published As

Publication number Publication date
AU6633681A (en) 1981-07-30
FR2473884B1 (fr) 1985-06-07
NZ196048A (en) 1984-07-31
NL8100259A (nl) 1981-08-17
CH647150A5 (de) 1985-01-15
AU552261B2 (en) 1986-05-29
BE887151A (fr) 1981-07-20
IT8147598A0 (it) 1981-01-20
US4571395A (en) 1986-02-18
DE3101644A1 (de) 1981-12-03
FR2473884A1 (fr) 1981-07-24
IT1142259B (it) 1986-10-08
JPS56104819A (en) 1981-08-20
CA1166157A (en) 1984-04-24
US4798826A (en) 1989-01-17
ZA81380B (en) 1982-08-25

Similar Documents

Publication Publication Date Title
SE8100276L (sv) Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar
SE8700499D0 (sv) Novel pharmacologically active compounds
ATE99927T1 (de) Pharmazeutische formulierungen.
ATE165973T1 (de) Sumatriptan enthaltende arzneimittel
SE8804629D0 (sv) New therapeutically active compounds
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
DE69322251D1 (de) Medizinische zusammensetzung
TR200101633T2 (tr) Farmasötik bileşim
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
DK122391D0 (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO167204C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diacylderivater av 4-(trialkylbenzyl)-piperazinylforbindelser.
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
PH19471A (en) Oxindole derivatives and pharmaceutical composition containing them
NO307496B1 (no) Anvendelse av en <delta>-opioid antagonist for fremstilling av et antitussivt middel
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
NO950177L (no) Farmakologisk aktive erivater
DE69529079D1 (de) Codein enthaltende formulierungen
RU94045140A (ru) Фармацевтическая композиция для профилактики или лечения вирусных заболеваний, способ ее получения и применение антагониста брадикинина или его физиологически переносимой соли в качестве средства для профилактики или лечения вирусных заболеваний
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8100276-8

Effective date: 19890124